CliffBio
small molecule

CEFOTAXIME SODIUM

CEFOTAXIME SODIUM

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameCEFOTAXIME SODIUM
Active ingredientCEFOTAXIME SODIUM
StrengthEQ 500MG BASE/VIAL
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalSeptember 2003
Marketing statusDISCN

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.